- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02128516
NUTRALYS® Pea Protein Oral Supplementation Effects on Muscle Mass (nutralys)
April 29, 2014 updated by: Nicolas Babault
Controlled, Randomized, Parallel, Double-blind Study of the Effect of NUTRALYS® Pea Protein Supplementation Versus Whey Protein and Placebo on the Muscle Mass and Strength of Volunteers Engaged in Training
this clinical trial would try to confirm whether NUTRALYS®, a fast pea protein with an intermediate profile, rich in leucines and other essential amino acids, can significantly enhance muscle mass gain during strength training.
This study will compare the efficacy of NUTRALYS® to a reference product.
If the results of the study demonstrate a significant improvement in relation to the placebo, not inferior to that of whey, NUTRALYS® could be considered as an alternative to sports nutrition products, to which many people are intolerant.
Study Overview
Study Type
Interventional
Enrollment (Actual)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Dijon, France, 21078
- Centre d'Expertise de la Performance
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male subjects from 18 to 35 years of age:
- engaged in moderate or occasional sports activity;
- having given their written informed consent;
- in gainful employment or a student;
- in possession of a medical certificate of fitness for sports
Exclusion Criteria:
- Subject already engaged in regular sports or training increasing muscle strength or volume in the upper limbs and particularly the biceps brachial;
- Subject engaged or having engaged in the last 6 months in weight training more than once a week;
- Subject having had a muscle injury in the 3 months prior to the study;
- Asthmatic subject liable to be administered corticosteroids;
- Subject taking part in another trial;
- Subject with a known hypersensitivity to whey or pea proteins;
- Subject deprived of their freedom for administrative, medical or legal reasons or not in possession of the legal or ethical capacity to enter into a contract due to cognitive function impairment;
- Subject liable not to comply with the constraints required by the protocol;
- Subject not covered by health insurance;
- Subject having taken in the previous month or currently taking: medication, a dietary supplement, sports drink, food for particular nutritional uses or functional foods, of any kind, liable or described as liable to increase physical performance and notably to increase muscle mass;
- Subject taking anabolic protein or corticosteroid treatment;
- Subject on a high-protein diet.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: placebo
|
Other Names:
|
Active Comparator: whey protein
|
Other Names:
|
Experimental: pea protein
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Biceps brachial thickness measured using ultrasonography
Time Frame: 12 weeks after first ingestion
|
biceps muscle thickness measured in millimeter using images from ultrasonography
|
12 weeks after first ingestion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Elbow flexor strength
Time Frame: 12 weeks after first ingestion
|
Elbow flexors muscle strength measured in Newton meter using a Biodex isokinetic dynamometer in concentric, eccentric and isometric conditions.
|
12 weeks after first ingestion
|
Biceps circumference
Time Frame: 12 weeks after first ingestion
|
the circumference of the arm in three sites (proximal, middle and distal) using a tape (centimeter)
|
12 weeks after first ingestion
|
body weight
Time Frame: 12 weeks after first ingestion
|
Body mass in kg on a scale
|
12 weeks after first ingestion
|
tolerance
Time Frame: 12 weeks after first ingestion
|
Tolerance measured by quantifying adverse events
|
12 weeks after first ingestion
|
muscle force
Time Frame: 12 weeks after first ingestion
|
maximal weight lifted during an arm curl exercise (kg)
|
12 weeks after first ingestion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Francois A Allaert, MD, CEN Nutriment
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
April 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
April 24, 2014
First Submitted That Met QC Criteria
April 29, 2014
First Posted (Estimate)
May 1, 2014
Study Record Updates
Last Update Posted (Estimate)
May 1, 2014
Last Update Submitted That Met QC Criteria
April 29, 2014
Last Verified
April 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- CEN1118
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on oral powder in sachet
-
Abbott NutritionCompleted
-
Liaquat University of Medical & Health SciencesNot yet recruiting
-
Danone Specialized Nutrition (M) Sdn BhdUniversiti Putra MalaysiaRecruiting
-
TorreyPines TherapeuticsCompletedHealthy | HyperalgesiaUnited States
-
Aimmune Therapeutics, Inc.Completed
-
Aimmune Therapeutics, Inc.CompletedPeanut AllergyUnited States, United Kingdom, France, Germany
-
Aimmune Therapeutics, Inc.CompletedPeanut AllergyUnited States, Spain, Ireland, Netherlands, Canada, United Kingdom, Germany, Denmark, Italy, Sweden
-
Aimmune Therapeutics, Inc.CompletedPeanut AllergyUnited Kingdom, Italy, France, Germany, Ireland, Spain, Sweden
-
Kantonsspital AarauTerminatedUrinary Tract InfectionsSwitzerland
-
Instituto BernabeuNot yet recruiting